Ocular Therapeutix IncNASDAQ:OCUL
- LAST PRICE4.7450
- TODAY'S CHANGE (%)0.5450 (12.9762%)
- Bid / Lots4.6400/ 1
- Ask / Lots4.8600/ 14
- Open / Previous Close4.1400 / 4.2000
- Day Range
- 52 Week Range
- Volume3,883,481
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OCUL |
|---|---|---|
| 09:32 ET | 42126 | 4.21 |
| 09:34 ET | 5658 | 4.1101 |
| 09:36 ET | 4781 | 4.095 |
| 09:38 ET | 9302 | 4.13 |
| 09:39 ET | 30604 | 4.14 |
| 09:41 ET | 13413 | 4.125 |
| 09:43 ET | 6017 | 4.145 |
| 09:45 ET | 13481 | 4.1499 |
| 09:48 ET | 14166 | 4.155 |
| 09:50 ET | 18650 | 4.16 |
| 09:52 ET | 4234 | 4.175 |
| 09:54 ET | 7945 | 4.176 |
| 09:56 ET | 15050 | 4.195 |
| 09:57 ET | 9153 | 4.185 |
| 09:59 ET | 11151 | 4.185 |
| 10:01 ET | 10232 | 4.13 |
| 10:03 ET | 10520 | 4.135 |
| 10:06 ET | 19827 | 4.135 |
| 10:08 ET | 12679 | 4.135 |
| 10:10 ET | 19671 | 4.14 |
| 10:12 ET | 8593 | 4.135 |
| 10:14 ET | 6963 | 4.145 |
| 10:15 ET | 1000 | 4.145 |
| 10:17 ET | 16220 | 4.145 |
| 10:19 ET | 6748 | 4.1312 |
| 10:21 ET | 2634 | 4.135 |
| 10:24 ET | 7138 | 4.135 |
| 10:26 ET | 17358 | 4.13 |
| 10:28 ET | 5354 | 4.135 |
| 10:30 ET | 11488 | 4.145 |
| 10:32 ET | 24279 | 4.14 |
| 10:33 ET | 700 | 4.145 |
| 10:35 ET | 10338 | 4.145 |
| 10:37 ET | 652 | 4.145 |
| 10:39 ET | 4370 | 4.135 |
| 10:42 ET | 30715 | 4.145 |
| 10:44 ET | 4225 | 4.1401 |
| 10:46 ET | 11421 | 4.131 |
| 10:48 ET | 5080 | 4.13 |
| 10:50 ET | 2645 | 4.1301 |
| 10:51 ET | 3724 | 4.13 |
| 10:53 ET | 10995 | 4.13 |
| 10:55 ET | 14633 | 4.135 |
| 10:57 ET | 3099 | 4.135 |
| 11:00 ET | 8892 | 4.135 |
| 11:02 ET | 7862 | 4.135 |
| 11:04 ET | 26313 | 4.155 |
| 11:06 ET | 11149 | 4.135 |
| 11:08 ET | 5200 | 4.13 |
| 11:09 ET | 8904 | 4.115 |
| 11:11 ET | 13778 | 4.1243 |
| 11:13 ET | 19229 | 4.12 |
| 11:15 ET | 5020 | 4.125 |
| 11:18 ET | 2848 | 4.125 |
| 11:20 ET | 1132 | 4.125 |
| 11:22 ET | 3800 | 4.11 |
| 11:24 ET | 22087 | 4.105 |
| 11:26 ET | 13343 | 4.105 |
| 11:27 ET | 14788 | 4.105 |
| 11:29 ET | 8144 | 4.115 |
| 11:31 ET | 30743 | 4.135 |
| 11:33 ET | 10546 | 4.12 |
| 11:36 ET | 2341 | 4.11 |
| 11:38 ET | 11039 | 4.125 |
| 11:40 ET | 4400 | 4.125 |
| 11:42 ET | 3246 | 4.125 |
| 11:44 ET | 2829 | 4.125 |
| 11:45 ET | 8564 | 4.165 |
| 11:47 ET | 1455 | 4.165 |
| 11:49 ET | 5690 | 4.185 |
| 11:51 ET | 8399 | 4.195 |
| 11:54 ET | 26563 | 4.16 |
| 11:56 ET | 50822 | 4.17 |
| 11:58 ET | 29431 | 4.175 |
| 12:00 ET | 150658 | 4.2007 |
| 12:02 ET | 164432 | 4.235 |
| 12:03 ET | 68036 | 4.23 |
| 12:05 ET | 9950 | 4.2 |
| 12:07 ET | 6936 | 4.205 |
| 12:09 ET | 10708 | 4.21 |
| 12:12 ET | 13145 | 4.2 |
| 12:14 ET | 11300 | 4.2 |
| 12:16 ET | 7197 | 4.215 |
| 12:18 ET | 1100 | 4.215 |
| 12:20 ET | 1648 | 4.215 |
| 12:21 ET | 1916 | 4.21 |
| 12:23 ET | 52257 | 4.245 |
| 12:25 ET | 54140 | 4.31 |
| 12:27 ET | 57076 | 4.355 |
| 12:30 ET | 21996 | 4.385 |
| 12:32 ET | 26627 | 4.3576 |
| 12:34 ET | 40785 | 4.385 |
| 12:36 ET | 9069 | 4.39 |
| 12:38 ET | 17475 | 4.385 |
| 12:39 ET | 6462 | 4.4 |
| 12:41 ET | 14768 | 4.4188 |
| 12:43 ET | 6214 | 4.429 |
| 12:45 ET | 8516 | 4.435 |
| 12:48 ET | 9100 | 4.415 |
| 12:50 ET | 12848 | 4.415 |
| 12:52 ET | 1601 | 4.415 |
| 12:54 ET | 36368 | 4.465 |
| 12:56 ET | 58214 | 4.505 |
| 12:57 ET | 13325 | 4.505 |
| 12:59 ET | 24276 | 4.4999 |
| 01:01 ET | 14020 | 4.49 |
| 01:03 ET | 21472 | 4.475 |
| 01:06 ET | 3703 | 4.485 |
| 01:08 ET | 14468 | 4.525 |
| 01:10 ET | 6270 | 4.52 |
| 01:12 ET | 5804 | 4.525 |
| 01:14 ET | 14178 | 4.5401 |
| 01:15 ET | 20280 | 4.525 |
| 01:17 ET | 18775 | 4.545 |
| 01:19 ET | 15551 | 4.565 |
| 01:21 ET | 38144 | 4.495 |
| 01:24 ET | 21932 | 4.4999 |
| 01:26 ET | 5225 | 4.495 |
| 01:28 ET | 5508 | 4.49 |
| 01:30 ET | 5399 | 4.49 |
| 01:32 ET | 17904 | 4.495 |
| 01:33 ET | 18900 | 4.4985 |
| 01:35 ET | 6003 | 4.495 |
| 01:37 ET | 2827 | 4.495 |
| 01:39 ET | 10395 | 4.495 |
| 01:42 ET | 5760 | 4.515 |
| 01:44 ET | 12626 | 4.505 |
| 01:46 ET | 7727 | 4.515 |
| 01:48 ET | 9890 | 4.535 |
| 01:50 ET | 7235 | 4.5325 |
| 01:51 ET | 33301 | 4.575 |
| 01:53 ET | 46537 | 4.6 |
| 01:55 ET | 4491 | 4.595 |
| 01:57 ET | 85463 | 4.595 |
| 02:00 ET | 17364 | 4.62 |
| 02:02 ET | 20221 | 4.6 |
| 02:04 ET | 21883 | 4.6 |
| 02:06 ET | 15846 | 4.615 |
| 02:08 ET | 20988 | 4.595 |
| 02:09 ET | 19670 | 4.615 |
| 02:11 ET | 15386 | 4.625 |
| 02:13 ET | 21151 | 4.647 |
| 02:15 ET | 44107 | 4.665 |
| 02:18 ET | 18294 | 4.655 |
| 02:20 ET | 7838 | 4.665 |
| 02:22 ET | 26222 | 4.645 |
| 02:24 ET | 6844 | 4.66 |
| 02:26 ET | 19602 | 4.71 |
| 02:27 ET | 25190 | 4.679 |
| 02:29 ET | 14191 | 4.675 |
| 02:31 ET | 8023 | 4.69 |
| 02:33 ET | 14727 | 4.7 |
| 02:36 ET | 42425 | 4.735 |
| 02:38 ET | 11396 | 4.7001 |
| 02:40 ET | 30026 | 4.7026 |
| 02:42 ET | 9403 | 4.71 |
| 02:44 ET | 7823 | 4.715 |
| 02:45 ET | 118225 | 4.745 |
| 02:47 ET | 4766 | 4.755 |
| 02:49 ET | 6227 | 4.715 |
| 02:51 ET | 5194 | 4.715 |
| 02:54 ET | 3804 | 4.725 |
| 02:56 ET | 14475 | 4.735 |
| 02:58 ET | 19449 | 4.74 |
| 03:00 ET | 6942 | 4.735 |
| 03:02 ET | 1700 | 4.7375 |
| 03:03 ET | 3408 | 4.7375 |
| 03:05 ET | 40669 | 4.705 |
| 03:07 ET | 6288 | 4.715 |
| 03:09 ET | 6380 | 4.725 |
| 03:12 ET | 13400 | 4.725 |
| 03:14 ET | 2973 | 4.725 |
| 03:16 ET | 5307 | 4.715 |
| 03:18 ET | 27627 | 4.705 |
| 03:20 ET | 11420 | 4.715 |
| 03:21 ET | 19036 | 4.7327 |
| 03:23 ET | 13866 | 4.74 |
| 03:25 ET | 14868 | 4.715 |
| 03:27 ET | 3408 | 4.72 |
| 03:30 ET | 540 | 4.725 |
| 03:32 ET | 11562 | 4.7279 |
| 03:34 ET | 24597 | 4.725 |
| 03:36 ET | 6973 | 4.72 |
| 03:38 ET | 976 | 4.71 |
| 03:39 ET | 12907 | 4.7 |
| 03:41 ET | 23746 | 4.705 |
| 03:43 ET | 16383 | 4.72 |
| 03:45 ET | 10560 | 4.725 |
| 03:48 ET | 13666 | 4.705 |
| 03:50 ET | 10051 | 4.715 |
| 03:52 ET | 35950 | 4.715 |
| 03:54 ET | 25935 | 4.715 |
| 03:56 ET | 87987 | 4.73 |
| 03:57 ET | 36233 | 4.74 |
| 03:59 ET | 62168 | 4.745 |
Apr 24, 2024
DJ Ocular Therapeutix Currently Down Nine Consecutive Days, On Pace for Longest Losing Streak Since October 2019 -- Data Talk, from 11:18AM ET on Wednesday Apr 24, 2024 by Dow Jones
11:18AM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 19, 2024
DJ Ocular Therapeutix Price Target Maintained With a $16.00/Share by HC Wainwright & Co., from 6:39AM ET on Friday Apr 19, 2024 by Dow Jones
6:39AM ET on Friday Apr 19, 2024 by Dow Jones
Apr 18, 2024
DJ Ocular Therapeutix Shares Dive on Axpaxli Trial Results, from 1:06PM ET on Thursday Apr 18, 2024 by Dow Jones
1:06PM ET on Thursday Apr 18, 2024 by Dow JonesOcular Therapeutix(TM) Announces Positive Topline Phase 1 Data for AXPAXLI(TM) in Diabetic Retinopathy, from 7:00AM ET on Thursday Apr 18, 2024 by Dow Jones
7:00AM ET on Thursday Apr 18, 2024 by Dow Jones
Apr 16, 2024
DJ Ocular Therapeutix Price Target Maintained With a $24.00/Share by JMP Securities, from 11:22AM ET on Tuesday Apr 16, 2024 by Dow Jones
11:22AM ET on Tuesday Apr 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ocular Therapeutix Inc | 705.2M | -4.8x | --- |
EyePoint Pharmaceuticals Inc | 834.7M | -9.1x | --- |
Theravance Biopharma Inc | 442.9M | -9.4x | --- |
Pliant Therapeutics Inc | 711.4M | -4.3x | --- |
Daiichi Sankyo Co Ltd | 62.7B | 48.7x | --- |
Aquestive Therapeutics Inc | 346.8M | -28.3x | --- |
Company Information
Ocular Therapeutix, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye. Its first commercial drug product, DEXTENZA, is for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis. It is also developing two other clinical-stage assets, OTX-DED (dexamethasone intracanalicular insert) for the short-term treatment of the signs and symptoms of dry eye disease, and OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease. It is conducting a pivotal Phase III clinical trial to evaluate AXPAXLI for the treatment of wet AMD. Its clinical portfolio also includes PAXTRAVA, which is in Phase III clinical development for the treatment of primary open-angle glaucoma (OAG) or ocular hypertension (OHT).
Contact Information
- Headquarters
- 15 Crosby DriveBEDFORD, MA, United States 01730
- Phone
- 781-357-4000
- Fax
- 781-357-4001
Executives
- Executive Chairman of the Board, President, Chief Executive Officer
- Pravin Dugel
- Chief Financial Officer
- Donald Notman
- Chief Technical Officer
- Peter Jarrett
- General Counsel
- Philip Strassburger
- Chief Commercial Officer
- Steve Meyers
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $705.2M |
|---|---|
Revenue (TTM) | $58.4M |
Shares Outstanding | 148.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.43 |
EPS | $-0.99 |
Book Value | $0.79 |
P/E Ratio | -4.8x |
Price/Sales (TTM) | 12.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -116.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
